Improved outcomes after De Novo renal transplantation:: 2-year results from the symphony study

被引：0
|
作者：
Ekberg, H. [1 ]
Tedesco-Silva, H. [2 ]
Demirbas, A.
Vitko, S.
Klempnauer, J. [3 ]
Gurkan, A.
Margreiter, R. [4 ]
Hugo, C. [5 ]
Grinyo, J.
Frei, U.
Vanrenterghem, Y. [6 ]
Daloze, P. [7 ]
Halloran, P. [8 ]
机构：
[1] Lund Univ, S-22100 Lund, Sweden
[2] Univ Fed Sao Paulo, Sao Paulo, Brazil
[3] Hannover Med Sch, Hannover, Germany
[4] Univ Klin Innsbruck, Innsbruck, Austria
[5] FAU Erlangen Nuernberg, Erlangen, Germany
[6] Katholieke Univ Leuven, Louvain, Belgium
[7] CHU Montreal, Montreal, PQ, Canada
[8] Univ Alberta, Edmonton, AB T6G 2M7, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [31] Percutaneous coronary intervention improved outcomes of cardiac arrest after acute myocardial infarction: a 2-year study
    Lei, Yuan-Li
    Chen, Shou-Quan
    Li, Zhang-Ping
    Xue, Ji-Ke
    Wang, Ting-Ting
    Zhou, Zhi-Liang
    Xu, Hua-Qing
    Lu, Ying-Ru
    Li, Hui-Ping
    Huang, Wei-Jia
    Cheng, Jun-Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 3097 - 3105
  • [32] De novo renal cystic disease after liver transplantation in children
    Franchi-Abella, Stephanie
    Mourier, Olivia
    Pariente, Daniele
    Bernard, Olivier
    Debray, Dominique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 224 - 224
  • [33] FTY720, a novel immunomodulator:: Efficacy and safety results from the first phase 2A study in de novo renal transplantation
    Tedesco-Silva, H
    Mourad, G
    Kahan, BD
    Boira, JG
    Weimar, W
    Mulgaonkar, S
    Nashan, B
    Madsen, S
    Charpentier, B
    Pellet, P
    Vanrenterghem, Y
    TRANSPLANTATION, 2005, 79 (11) : 1553 - 1560
  • [34] FTY720, a novel immunomodulator:: Efficacy and safety results from the first phase 2A study in de novo renal transplantation
    Tedesco-Silva, H
    Mourad, G
    Kahan, BD
    Boira, JG
    Weimar, W
    Mulgaonkar, S
    Nashan, B
    Madsen, S
    Charpentier, B
    Pellet, P
    Vanrenterghem, Y
    TRANSPLANTATION, 2004, 77 (12) : 1826 - 1833
  • [35] Characteristics, outcomes, and predictors of de novo malignancy after heart transplantation
    Youn, Jong-Chan
    Kim, Darae
    Kim, In-Cheol
    Lee, Hye Sun
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Nishihara, Keith
    Kransdorf, Evan P.
    Chang, David H.
    Kittleson, Michelle M.
    Patel, Jignesh K.
    Ramzy, Danny
    Esmailian, Fardad
    Kobashigawa, Jon A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] Outcomes and mortality of de novo autoimmune hepatitis after liver transplantation
    Kuchipudi, Aishwarya
    Morton, Ryan
    Chan, Sarah Y.
    Moonka, Dilip
    Brown, Kimberly Ann
    Jafri, Syed M.
    HEPATOLOGY, 2015, 62 : 367A - 367A
  • [37] Current trends in the management of de novo allograft renal tumour after renal transplantation
    Chua, D.
    Rhee, H.
    Paterdis, J.
    Preston, J.
    Lawson, M.
    BJU INTERNATIONAL, 2018, 121 : 76 - 77
  • [38] Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry
    Hariharan, S
    Adams, MB
    Brennan, DC
    Davis, CL
    First, MR
    Johnson, CP
    Ouseph, R
    Peddi, VR
    Pelz, C
    Roza, AM
    Vincenti, F
    George, V
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 223 - 224
  • [39] Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study
    Netuka, Ivan
    Litzler, Pierre-Yves
    Berchtold-Herz, Michael
    Flecher, Erwan
    Zimpfer, Daniel
    Damme, Laura
    Sundareswaran, Kartik S.
    Farrar, David J.
    Schmitto, Jan D.
    ANNALS OF THORACIC SURGERY, 2017, 103 (04): : 1262 - 1269
  • [40] Everolimus in de novo pediatric renal transplantation:: Results at 24 months.
    Ettenger, R
    Moeller, VM
    Hoyer, PF
    Lemire, J
    Mahan, J
    Webb, N
    Niaudet, P
    Jaffe, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 575 - 575
12345